Stock Information
4D Molecular Therapeutics Inc (FDMT)
Ticker Symbol: FDMT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $451.15 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.744
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -47.27%
Latest News
-
HC Wainwright & Co. Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target
Fri, Mar 20, 2026 6:35 AM
-
RBC Capital Maintains Outperform on 4D Molecular Therapeutics, Raises Price Target to $35
Thu, Mar 19, 2026 10:04 AM
-
UPDATE: 4D Molecular Therapeutics Q4 EPS $0.43 Beats $(0.53) Estimate, Sales $85.090M Beat $32.245M Estimate
Wed, Mar 18, 2026 4:34 PM
Key Financials
Financial data not available
